Hims & Hers Health (HIMS) Common Equity (2019 - 2026)

Hims & Hers Health (HIMS) has 8 years of Common Equity data on file, last reported at $446.2 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 18.77% year-over-year to $446.2 million; the trailing twelve-month figure through Mar 2026 stood at $446.2 million (down 18.77% YoY), and the FY2025 full-year result was $540.9 million, up 13.47% from the prior year.
• Common Equity slipped to $446.2 million in Q1 2026, from $540.9 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $581.0 million in Q3 2025 to a low of $310.9 million in Q3 2022.
• A 5-year average of $404.6 million and a median of $344.5 million in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity jumped 59.45% in 2025 and retreated 18.77% in 2026, its largest moves.
• Tracing HIMS's Common Equity over 5 years: stood at $311.7 million in 2022, then rose by 10.36% to $344.0 million in 2023, then jumped by 38.57% to $476.7 million in 2024, then increased by 13.47% to $540.9 million in 2025, then fell by 17.52% to $446.2 million in 2026.
• Business Quant data shows HIMS's Common Equity at $446.2 million in Q1 2026, $540.9 million in Q4 2025, and $581.0 million in Q3 2025.